iShares Biotechnology ETF (NASDAQ:IBB) Shares Purchased by Wealthspire Advisors LLC

Wealthspire Advisors LLC boosted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Get Rating) by 29.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,486 shares of the financial services provider’s stock after purchasing an additional 3,933 shares during the quarter. Wealthspire Advisors LLC’s holdings in iShares Biotechnology ETF were worth $2,045,000 as of its most recent SEC filing.

Guidewire Software (GWRE) to Release Quarterly Earnings on Monday

Guidewire Software (NYSE:GWRE – Get Rating) is scheduled to be announcing its earnings results after the market closes on Monday, March 6th. Analysts expect the company to announce earnings of ($0.04) per share for the quarter. Guidewire Software has set its FY 2023 guidance at EPS and its Q2 2023 guidance at EPS.Investors that wish to register for the company’s conference call can do so using this link.

Whitbread plc (LON:WTB) Given Average Recommendation of “Buy” by Brokerages

Whitbread plc (LON:WTB – Get Rating) has been assigned a consensus recommendation of “Buy” from the nine ratings firms that are presently covering the company, MarketBeat reports. Nine investment analysts have rated the stock with a buy rating. The average twelve-month price target among brokers that have issued a report on the stock in the last year is GBX 3,635 ($43.77).

89bio, Inc. (NASDAQ:ETNB) Receives Average Rating of “Buy” from Brokerages

Shares of 89bio, Inc. (NASDAQ:ETNB – Get Rating) have received a consensus recommendation of “Buy” from the eight ratings firms that are covering the firm, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $25.63.

Crown Holdings, Inc. (NYSE:CCK) Shares Sold by Gabelli Funds LLC

Gabelli Funds LLC reduced its stake in shares of Crown Holdings, Inc. (NYSE:CCK – Get Rating) by 2.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 179,850 shares of the industrial products company’s stock after selling 4,562 shares during the quarter. Gabelli Funds LLC owned 0.15% of Crown worth $14,573,000 as of its most recent filing with the Securities and Exchange Commission.

Editas Medicine, Inc. (NASDAQ:EDIT) Holdings Raised by PDT Partners LLC

PDT Partners LLC grew its stake in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) by 43.5% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 124,758 shares of the company’s stock after acquiring an additional 37,793 shares during the period. PDT Partners LLC owned 0.18% of Editas Medicine worth $1,527,000 as of its most recent SEC filing.

error: Content is protected !!